Skip to main content

Tax receipts

Your 2020-2021 tax receipt will be sent mid-July. Contact us if you need to update your details.

Contact us

Our ongoing studies have successfully developed a novel mouse model of thrombolysis (iCAT) that for the first time allows us the ability to examine the efficacy of novel drugs including novel thrombin inhibitors to facilitate clot lysis (recanalization), restore perfusion in the brain, as well as determine whether cerebral damage and cognitive impairment associated with stroke are reduced. We are using this model to assess the efficacy of currently approved and novel anticlotting agents to facilitate stroke treatment.

EOFY tax receipts will be sent mid-July

Contact us